AFC-HD AMS Life Science Co

AFC-HD AMS Life Science Co OCF Margin

The Operating Cash Flow Margin of AFC-HD AMS Life Science Co (2927.T) as of Nov 4, 2026 is 4.89 %. In the previous year, Operating Cash Flow Margin was 5.47 % — a change of -10.65% (lower).

OCF Margin

4.89 %

YoY

-10.65%

Last updated:

Operating Cash Flow Margin of AFC-HD AMS Life Science Co is 2026 4.89 % . Operating Cash Flow Margin of AFC-HD AMS Life Science Co was 2025 5.47 % . It decreases by -10.65% lower compared to the previous year.

The AFC-HD AMS Life Science Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
6.96 JPY
Jan 1, 2020
8.21 JPY
Jan 1, 2021
11.55 JPY
Jan 1, 2022
6.49 JPY
Jan 1, 2023
3.38 JPY
Jan 1, 2024
5.10 JPY
Jan 1, 2025
5.47 JPY
Jan 1, 2026
4.89 JPY
The AFC-HD AMS Life Science Co OCF Margin history
YEAROCF MarginYoY
4.89 %-10.65%
5.47 %+7.25%
5.10 %+50.83%
3.38 %-47.87%
6.49 %-43.80%
11.55 %+40.61%
8.21 %+17.91%
6.96 %-9.95%
7.73 %+122.81%
3.47 %-40.56%
5.84 %-1.75%
5.94 %-8.61%
6.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

AFC-HD AMS Life Science Co Stock analysis

What does AFC-HD AMS Life Science Co do? AFC-HD AMS Life Science Co., Ltd. generates revenue through its Healthcare segment, which produces and sells health foods, cosmetics, and OEM services for other brands. The Pharmaceutical segment manufactures and sells ethical drugs, over-the-counter drugs, and generic medicines. The company also manages restaurants via a subsidiary, contributing to its diversified income streams. Customers include businesses seeking OEM partnerships and consumers purchasing health and pharmaceutical products. The firm's products are sold under its own brand and through OEM agreements, targeting both individual consumers and corporate clients. The Healthcare segment focuses on wellness products, while the Pharmaceutical segment caters to medical needs with prescription and non-prescription drugs. The restaurant management subsidiary provides additional revenue from food service operations. Revenue is derived from the sale of health foods, cosmetics, Chinese medicine medicines, general medicines, and healthcare products within the Healthcare segment. The Pharmaceutical segment's income comes from ethical drugs, over-the-counter drugs, and generic medicines. The restaurant subsidiary's operations further support the company's financial structure through food service sales. AFC-HD AMS Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AFC-HD AMS Life Science Co stock

Operating Cash Flow Margin of AFC-HD AMS Life Science Co is 4.89 % in 2026.

Operating Cash Flow Margin of AFC-HD AMS Life Science Co changed from 5.47 % to 4.89 %, representing a -10.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin AFC-HD AMS Life Science Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's AFC-HD AMS Life Science Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — AFC-HD AMS Life Science Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — AFC-HD AMS Life Science Co